Left Ventricular Remodeling and Ventricular Arrhythmias After Myocardial Infarction

Background—The relation between left ventricular (LV) remodeling and ventricular arrhythmias after myocardial infarction is poorly documented. We investigated the relations between LV size, hypertrophy, and function and ventricular arrhythmias in 263 patients from the Survival and Ventricular Enlargement (SAVE) study, using quantitative 2D echocardiography and ambulatory ECG monitoring after myocardial infarction. Methods and Results—Transthoracic 2D echocardiograms and arrhythmia monitoring were performed at baseline (mean, 11 days) and 1 and 2 years after infarction. LV size, short-axis muscle (mass) area (LVMA), and function were quantified from 2D echocardiograms. The prevalence of ventricular tachycardia (VT) and frequent ventricular ectopy (premature ventricular contractions [PVCs] >10/h) was assessed from ambulatory ECG. VT and PVCs >10/h occurred in 20% and 29% of patients at baseline, in 22% and 35% at 1 year and 23% and 39% at 2 years, respectively. VT and PVCs >10/h at baseline and 1 and 2 years were significantly related to LV size, LVMA, and function. Furthermore, changes in LV size and function from baseline to 2 years predicted both VT and PVCs >10/h. The study was underpowered to detect treatment effect of ACE inhibitors and &bgr;-adrenergic receptor blockers but did not alter the relations between ventricular arrhythmias, LV size, and function. Conclusions—Quantitative echocardiographic assessment of LV size, LVMA, and function and changes in these measurements over time predict ventricular arrhythmias after infarction. Altered LV architecture and function during postinfarction LV remodeling provide an important substrate for triggering high-grade ventricular arrhythmias.

[1]  S. Tyagi,et al.  Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts , 1996, Molecular and Cellular Biochemistry.

[2]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[3]  I. V. Van Gelder,et al.  Electrophysiological changes of angiotensin-converting enzyme inhibition after myocardial infarction. , 2000, Journal of cardiac failure.

[4]  P. Libby,et al.  Echocardiography-derived left ventricular end-systolic regional wall stress and matrix remodeling after experimental myocardial infarction. , 1999, Journal of the American College of Cardiology.

[5]  M. Pfeffer,et al.  Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. , 1999, Journal of the American College of Cardiology.

[6]  J. Rouleau,et al.  Postinfarction survival and inducibility of ventricular arrhythmias in the spontaneously hypertensive rat : effects of ramipril and hydralazine. , 1998, Circulation.

[7]  K. Weber,et al.  Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. , 1997, Circulation.

[8]  G. Lamas,et al.  Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. , 1997, Circulation.

[9]  K. Lie,et al.  Left ventricular dilatation and high-grade ventricular arrhythmias in the first year after myocardial infarction. CATS Investigators. Captopril and Thrombolysis Study. , 1994, Journal of cardiac failure.

[10]  G. Lamas,et al.  Quantitative Two-Dimensional Echocardiographic Measurements are Major Predictors of Adverse Cardiovascular Events After Acute Myocardial Infarction: The Protective Effect of Captopril , 1994, Circulation.

[11]  G. Lamas,et al.  Activation of neurohumoral systems in postinfarction left ventricular dysfunction. , 1993, Journal of the American College of Cardiology.

[12]  Peter Gaudron,et al.  Progressive Left Ventricular Dysfunction and Remodeling After Myocardial Infarction Potential Mechanisms and Early Predictors , 1993, Circulation.

[13]  Jeffrey E. Saffitz,et al.  Reentrant and Focal Mechanisms Underlying Ventricular Tachycardia in the Human Heart , 1992, Circulation.

[14]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[15]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[16]  J. Sadoshima,et al.  Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. , 1992, The Journal of biological chemistry.

[17]  R. Aronson Mechanisms of Arrhythmias in Ventricular Hypertrophy , 1991 .

[18]  J. Jalife,et al.  Cardiac Electrophysiology: From Cell to Bedside , 1990 .

[19]  M. Pfeffer,et al.  Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.

[20]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[21]  S. Houser,et al.  Outward currents in normal and hypertrophied feline ventricular myocytes. , 1989, The American journal of physiology.

[22]  David W. Hosmer,et al.  Best subsets logistic regression , 1989 .

[23]  S. Houser,et al.  Calcium currents in normal and hypertrophied isolated feline ventricular myocytes. , 1988, The American journal of physiology.

[24]  M. Allessie,et al.  Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts. , 1988, Circulation research.

[25]  Pierre L. Page,et al.  Anisotropic conduction and functional dissociation of ischemic tissue during reentrant ventricular tachycardia in canine myocardial infarction. , 1988, Circulation.

[26]  D. Levy,et al.  Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. , 1987, The American journal of cardiology.

[27]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[28]  F. Witkowski,et al.  Mechanisms controlling cardiac autonomic function and their relation to arrhythmogenesis , 1986 .

[29]  H. Fozzard,et al.  The Heart and cardiovascular system : scientific foundations , 1986 .

[30]  J. Weiss,et al.  Early dilation of the infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute left ventricular enlargement. , 1984, Journal of the American College of Cardiology.

[31]  R. Klein,et al.  Ventricular arrhythmias in aortic valve disease: analysis of 102 patients. , 1984, The American journal of cardiology.

[32]  J P Miller,et al.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. , 1984, Circulation.

[33]  D A Richards,et al.  Electrophysiologic substrate for ventricular tachycardia: correlation of properties in vivo and in vitro. , 1984, Circulation.

[34]  A. L. Simon,et al.  Left Ventricular Size after Acute Myocardial Infarction: Serial Changes and their Prognostic Significance , 1973, Circulation.